Vivek Ramaswamy - Net Worth and Insider Trading
Vivek Ramaswamy Net Worth
The estimated net worth of Vivek Ramaswamy is at least $633 Million dollars as of 2024-11-13. Vivek Ramaswamy is the Director of Roivant Sciences Ltd and owns about 54,409,211 shares of Roivant Sciences Ltd (ROIV) stock worth over $633 Million. Details can be seen in Vivek Ramaswamy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vivek Ramaswamy has not made any transactions after 2023-02-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Vivek Ramaswamy
Vivek Ramaswamy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vivek Ramaswamy owns 4 companies in total, including Arbutus Biopharma Corp (ABUS) , Myovant Sciences Ltd (MYOV) , and Sio Gene Therapies Inc (SIOX) among others .
Click here to see the complete history of Vivek Ramaswamy’s form 4 insider trades.
Insider Ownership Summary of Vivek Ramaswamy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 2018-06-19 | director |
| MYOV | Myovant Sciences Ltd | 2016-10-26 | director |
| SIOX | Sio Gene Therapies Inc | 2015-06-10 | director & 10 percent owner & Principal Executive Officer |
 | | 2023-02-22 | director |
Vivek Ramaswamy Latest Holdings Summary
Vivek Ramaswamy currently owns a total of 1 stock. Vivek Ramaswamy owns 54,409,211 shares of Roivant Sciences Ltd (ROIV) as of February 22, 2023, with a value of $633 Million.
Latest Holdings of Vivek Ramaswamy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd | 2023-02-22 | 54,409,211 | 11.64 | 633,323,216 |
Holding Weightings of Vivek Ramaswamy
Vivek Ramaswamy Form 4 Trading Tracker
According to the SEC Form 4 filings, Vivek Ramaswamy has made a total of 1 transactions in Roivant Sciences Ltd (ROIV) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Roivant Sciences Ltd is the sale of 4,000,000 shares on February 22, 2023, which brought Vivek Ramaswamy around $32 Million.
Insider Trading History of Vivek Ramaswamy
- 1
Vivek Ramaswamy Trading Performance
Vivek Ramaswamy Ownership Network
Ownership Network List of Vivek Ramaswamy
Ownership Network Relation of Vivek Ramaswamy
Vivek Ramaswamy Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Vivek Ramaswamy is the director of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Vivek Ramaswamy made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .
In summary, during the past 3 months, insiders sold 8,846 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 8,846 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Vivek Ramaswamy Mailing Address
Above is the net worth, insider trading, and ownership report for Vivek Ramaswamy. You might contact Vivek Ramaswamy via mailing address: C/o Oncore Biopharma, Inc., 3805 Old Easton Road, Doylestown Pa 18902.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
